Organon & Co. (OGN)
NYSE: OGN · Real-Time Price · USD
13.50
+0.03 (0.22%)
At close: Jun 26, 2026, 4:00 PM EDT
13.50
0.00 (0.00%)
Pre-market: Jun 29, 2026, 4:56 AM EDT
Organon & Co. Market Cap
Organon & Co. has a market cap or net worth of $3.55 billion as of June 29, 2026. Its market cap has increased by 35.29% in one year.
Market Cap
3.55B
Enterprise Value
11.00B
1-Year Change
35.29%
Ranking
Category
Stock Price
$13.50
Market Cap Chart
Since May 14, 2021, Organon & Co.'s market cap has decreased from $8.42B to $3.55B, a decrease of -57.88%. That is a compound annual growth rate of -15.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 3.55B | 90.18% |
| Dec 31, 2025 | 1.86B | -51.49% |
| Dec 31, 2024 | 3.84B | 4.25% |
| Dec 29, 2023 | 3.69B | -48.12% |
| Dec 30, 2022 | 7.10B | -7.98% |
| Dec 31, 2021 | 7.72B | -8.27% |
| May 14, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 214.87B |
| Amgen | 193.39B |
| Gilead Sciences | 158.77B |
| Pfizer | 138.44B |
| Bristol-Myers Squibb Company | 117.46B |
| GSK plc | 104.43B |
| Sanofi | 102.76B |
| Biogen | 31.89B |